Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 20, 2024 - Issue 5
Submit an article Journal homepage
323
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Cephalosporins with warfarin increase the risk of bleeding: myth or fact?

Abrar K. Thabita Pharmacy Practice Department, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi ArabiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0369-9094View further author information
ORCID Icon,
Samaher Y. Almoalimb Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi ArabiaView further author information
&
Rahaf Altalhic Eastern Health Cluster, Ministry of Health, Dammam, Saudi ArabiaView further author information
Pages 293-296 | Received 07 Feb 2024, Accepted 26 Apr 2024, Published online: 09 May 2024

References

  • Vega AJ, Smith C, Matejowsky HG, et al. Warfarin and antibiotics: drug interactions and clinical considerations. Life (Basel). 2023 Jul 30;13(8). doi: 10.3390/life13081661
  • Product information: ROCEPHIN®, ceftriaxone sodium for injection. Nutley (NJ): Roche Laboratories Inc; 2018.
  • Mause E, Selim M, Velagapudi M. Cefazolin-induced hemolytic anemia: a case report and systematic review of literature. Eur J Med Res. 2021 Nov 24;26(1):133. doi: 10.1186/s40001-021-00604-9
  • Leicht HB, Weinig E, Mayer B, et al. Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature. BMC Pharmacol Toxicol. 2018 Oct 25;19(1):67. doi: 10.1186/s40360-018-0257-7
  • Kawamoto K, Touchi A, Sugeno K, et al. In vitro effect of beta-lactam antibiotics and N-methyltetrazolethiol on microsomal vitamin K epoxide reductase in rats. Jpn J Pharmacol. 1988 Jun;47(2):169–178. doi: 10.1016/S0021-5198(19)43231-9
  • Angaran DM, Dias VC, Arom KV, et al. The comparative influence of prophylactic antibiotics on the prothrombin response to warfarin in the postoperative prosthetic cardiac valve patient. Cefamandole, cefazolin, vancomycin. Ann Surg. 1987 Aug;206(2):155–161. doi: 10.1097/00000658-198708000-00007
  • Baillargeon J, Holmes HM, Lin YL, et al. Concurrent use of warfarin and antibiotics and the risk of bleeding in older adults. Am J Med. 2012 Feb;125(2):183–189. doi: 10.1016/j.amjmed.2011.08.014
  • Saum LM, Balmat RP. Ceftriaxone potentiates warfarin activity greater than other antibiotics in the treatment of urinary tract infections. J Pharm Pract. 2016 Apr;29(2):121–124. doi: 10.1177/0897190014544798
  • Teklay G, Shiferaw N, Legesse B, et al. Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study. Thromb J. 2014;12(1):20. doi: 10.1186/1477-9560-12-20
  • Yagi T, Naito T, Kato A, et al. Association between the prothrombin time-international normalized ratio and concomitant use of antibiotics in warfarin users: focus on type of antibiotic and susceptibility of bacteroides fragilis to antibiotics. Ann Pharmacother. 2021 Feb;55(2):157–164. doi: 10.1177/1060028020940728
  • Imai S, Kadomura S, Momo K, et al. Comparison of interactions between warfarin and cephalosporins with and without the N-methyl-thio-tetrazole side chain. J Infect Chemother. 2020 Nov;26(11):1224–1228. doi: 10.1016/j.jiac.2020.07.014
  • Clark TR, Burns S. Elevated international normalized ratio values associated with concomitant use of warfarin and ceftriaxone. Am J Health Syst Pharm. 2011 Sep 1;68(17):1603–1605. doi: 10.2146/ajhp100681
  • Bohm NM, Crosby B. Hemarthrosis in a patient on warfarin receiving ceftaroline: a case report and brief review of cephalosporin interactions with warfarin. Ann Pharmacother. 2012 Jul;46(7–8):e19. doi: 10.1345/aph.1Q771
  • Farhat NM, Hutchinson LS, Peters M. Elevated international normalized ratio values in a patient receiving warfarin and ceftaroline. Am J Health Syst Pharm. 2016 Jan 15;73(2):56–59. doi: 10.2146/ajhp140897
  • Chartier AR, Hillert CJ, Gill H, et al. Acquired factor V inhibitor after antibiotic therapy: a clinical case report and review of the literature. Cureus. 2020 Jul 30;12(7):e9481. doi: 10.7759/cureus.9481

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.